EUDA Health Holdings Ltd (EUDA): Nasdaq/NYSE listing notice — EUDA Health regains Nasdaq compliance on discounted share issuance; gets Aug 4 deadline for late filings

EUDA Health Holdings Ltd

Nasdaq confirmed EUDA regained compliance with Listing Rule 5635(c) after CEO forfeited 271,867 shares to eliminate the discount on a $850,306 loan settlement.
Nasdaq accepted EUDA's plan to file overdue 10-K (FY2022) and 10-Q (Q1 2023) by August 4, 2023 to avoid potential delisting.
If EUDA fails to file by August 4, 2023, it may receive a delisting notice but can appeal to a Nasdaq Hearings Panel.

item 3.01 item 8.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

EUDA Health Holdings Ltd received a nasdaq compliance regained notice regarding other (rules 5635(c)).

Exchange: nasdaq
Notice: compliance regained
Rules: 5635(c)

Exact text from the filing

June 13, 2023, the Company received a letter from Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) citing the Company’s initial non-compliance of Nasdaq Listing Rule 5635(c) but that it has regained compliance with Nasdaq Listing Rule 5635(c) because of the share forfeiture pursuant to the Supplemental Agreement.

View on SEC.gov

Browse all listing & compliance notices →

EUDA Health Holdings Ltd filing history →

Source: SEC EDGAR

accession 0001493152-23-021404

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.